Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Yarmolinsky

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of the National Cancer Institute|September 23, 2025
Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysisEmma Hazelwood, Lucy J Goudswaard, Matthew A Lee, et al.
Plos Medicine|February 3, 2022
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysisJames Yarmolinsky, Virginia Díez-Obrero, Tom G Richardson, et al.
Journal of Leukocyte Biology|September 20, 2025
Transcriptome-wide Mendelian randomization exploring dynamic CD4+ T cell gene expression in colorectal cancer developmentBenedita Deslandes, Xueyan Wu, Matthew A Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
Transcriptome-wide Mendelian randomisation exploring dynamic CD4+ T cell gene expression in colorectal cancer developmentBenedita Deslandes, Xueyan Wu, Matthew A Lee, et al.
Nature Communications|March 15, 2026
TYK2 mediates neuroinflammation in Alzheimer's disease brains with TDP-43 pathologyLaura E König, Steve Rodriguez, Clemens Hug, et al.
Diabetologia|May 12, 2023
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysisJames Yarmolinsky, Emmanouil Bouras, Andrei Constantinescu, et al.
International Journal of Epidemiology|May 10, 2024
Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysisEmmanouil Bouras, Dipender Gill, Verena Zuber, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2021
Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization StudyNiki Dimou, James Yarmolinsky, Emmanouil Bouras, et al.
International Journal of Cancer|June 23, 2026
Immune Markers and Risk of Pancreatic Cancer in the European EPIC CohortVerena A Katzke, Yue Chen, Srimanti Dutta, et al.
Nature Communications|April 29, 2024
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancersKarl Smith-Byrne, Åsa Hedman, Marios Dimitriou, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of the National Cancer Institute|September 23, 2025
Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysisEmma Hazelwood, Lucy J Goudswaard, Matthew A Lee, et al.
Plos Medicine|February 3, 2022
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysisJames Yarmolinsky, Virginia Díez-Obrero, Tom G Richardson, et al.
Journal of Leukocyte Biology|September 20, 2025
Transcriptome-wide Mendelian randomization exploring dynamic CD4+ T cell gene expression in colorectal cancer developmentBenedita Deslandes, Xueyan Wu, Matthew A Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
Transcriptome-wide Mendelian randomisation exploring dynamic CD4+ T cell gene expression in colorectal cancer developmentBenedita Deslandes, Xueyan Wu, Matthew A Lee, et al.
Nature Communications|March 15, 2026
TYK2 mediates neuroinflammation in Alzheimer's disease brains with TDP-43 pathologyLaura E König, Steve Rodriguez, Clemens Hug, et al.
Diabetologia|May 12, 2023
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysisJames Yarmolinsky, Emmanouil Bouras, Andrei Constantinescu, et al.
International Journal of Epidemiology|May 10, 2024
Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysisEmmanouil Bouras, Dipender Gill, Verena Zuber, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2021
Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization StudyNiki Dimou, James Yarmolinsky, Emmanouil Bouras, et al.
International Journal of Cancer|June 23, 2026
Immune Markers and Risk of Pancreatic Cancer in the European EPIC CohortVerena A Katzke, Yue Chen, Srimanti Dutta, et al.
Nature Communications|April 29, 2024
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancersKarl Smith-Byrne, Åsa Hedman, Marios Dimitriou, et al.
Pageof 7